- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Godavari Biorefineries Limited (GBL) has secured a strategic international license agreement with Catalyxx Inc., granting it exclusive rights to utilize Catalyxx’s technology for converting ethanol into biobutanol and higher alcohols, with a target production of up to 30,000 tons annually. Initially, GBL plans to construct a facility capable of producing 15,000 metric tons of biobutanol each year, marking a significant advancement in its sustainability initiatives.
This partnership positions GBL as a leader in the bio-based chemicals market, enhancing its product offerings with renewable solutions. The new biobutanol plant is set to become a benchmark for innovation in the industry, aligning with the global push toward green chemistry. Both companies share a vision for sustainability, and this collaboration is expected to drive substantial positive impacts on environmental efforts and GBL's business performance. Investors should view this development as a positive signal of growth potential and market leadership in sustainable technologies.